AZ links with Berg in AI-based drug discovery deal
AstraZeneca and US biopharma Berg have entered a research pact to identify and evaluate novel targets and therapeutics to treat neurological disorders with the help of artificial intelligence. AZ also announced expanded approval in the US of breast cancer drug Faslodex.
Read More
